Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction

Molecules(2020)10.3390/molecules25245905Source: DataRank Database

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction is a research paper published in Molecules (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.91)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Shabnam Malik,Anyssa Rodriguez,Murali M. Yallapu ORCID,Acharan S. Narula,Sanjaya K. Satapathy ORCID

Live enrichment

PubMed:33322162 PMC:PMC7764432 OpenAlex:https://openalex.org/W3113036654

National Institutes of Health

Grant: R01 CA210192

National Institutes of Health

Grant: 5R01CA204552-03

MUC13 Mucin in Colorectal Cancer Health Disparity

National Institutes of Health

Grant: 7R01CA210192-05

Targeted Nanotherapy for Pancreatic Cancer

National Institutes of Health

Grant: 1R01CA206069-01A1

Development of Targeted Nanotechnology Platform for Pancreatic Cancer

FWCI

1.91

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/25/24/5905/pdf?version=1607917228

publisherhttps://www.mdpi.com/1420-3049/25/24/5905/pdf?version=1607917228

publisherhttps://www.mdpi.com/1420-3049/25/24/5905/pdf

journalhttps://doi.org/10.3390/molecules25245905

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33322162

Fields of Study

Drug-Induced Hepatotoxicity and ProtectionPharmacological Effects of Natural CompoundsVitamin C and Antioxidants Research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAntiviral AgentsHumansDietary SupplementsChemical and Drug Induced Liver InjuryPandemics

Keywords

NutraceuticalPandemicCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicinePhytochemicalTraditional medicineVirologyDiseasePathologyCoronavirusACE2Hepatoprotective AgentsNutraceuticalsHepatic DysfunctionsCovid-19Sars-cov-2Organic chemistryReviewAntiviral AgentsCOVID-19 Drug TreatmentQD241-441Dietary SupplementsHumansChemical and Drug Induced Liver InjuryPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)